It’s difficult to overstate the kind of impact that a fantastic PowerPoint presentation can achieve. By blending multiple media, senses, and learning styles into a single presentation, PowerPoint has ...

From scholarly lectures to TED-style talks, from academic posters to interactive workshops, we engage with audiences ranging from field experts to the general public. This multi-faceted approach to ...

PowerPoint’s layouts and templates hold the key to transforming your ideas into visually striking presentations that captivate your audience. These tools aren’t just for designers—they’re ...

Thousand Oaks, Calif.-based Capsida Biotherapeutics (Capsida) has announced its slate of seven scientific presentations, three oral and four in poster form, that have been accepted for the 28th Annual ...

Oral and poster presentations will highlight advancements from ElevateBio's two business units: Life Edit, its gene editing and R&D technology business, and BaseCamp ®, its process development and ...

The poster presentations will include preclinical safety and efficacy results, highlighting STRO-004's significant anti-tumor activity and safety profile. Sutro's CEO, Jane Chung, expressed ...

A copy of the presentation materials can be accessed on the "Publication” section of the Company's website at www.bioatla.com once the presentations have concluded. BioAtla is a global clinical-stage ...

Enliven is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics to help people not only live longer, but live better. Enliven aims to ...

In contrast to an oral presentation ... When you finish designing your poster, save a copy as an image file (JPG or PNG), a PDF, or a Slide Deck (Google Slides or PowerPoint). Your choice of file type ...

4 IDEAYA/GSK presentations of IDE275 (GSK959) and 4 additional presentations across IDE397/MAT2A, IDE161/PARG, PRMT5, and KAT6/7 programs at AACR 2025 IDE275 (GSK959) has demonstrated a potential best ...

Erasca will also present potential first-in-class examples of direct SMP complex inhibitors, representing a new approach to block the RAS/MAPK pathway SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE ...

SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies ...